Comparison of low-dose ketamine to methadone for postoperative pain in opioid addicts: a randomized clinical trial.
Anesthesia and pain medicine – July 01, 2024
Source: PubMed
Summary
Managing pain after surgery in patients with addiction presents unique challenges. A groundbreaking clinical trial found that low-dose ketamine works just as effectively as methadone for postoperative pain control in patients with opioid addiction. The study tracked 220 patients, comparing pain levels and side effects between those receiving ketamine versus methadone. Both medications performed equally well, with similar safety profiles and pain relief outcomes.
Abstract
Postoperative pain can lead to several complications. The effectiveness of different opioids in relieving pain after surgery has been widely studied. However, managing pain in patients with opioid addiction is still challenging. This study aimed to examine the impact of ketamine and methadone on postoperative pain in patients with addiction. This was a non-inferiority randomized clinical trial. All included patients were monitored for morphine use, pain scores, and vital signs every 3 h. The intervention group received 0.5 mg/kg ketamine administered intravenously every 6 h. The control group received 5 mg of methadone intramuscularly every 8 h. The patient received intravenous morphine if their visual analog scale was above 3. All side effects in each group were recorded. Two hundred and twenty patients were included in this study. There were 127 men (57.7%) with an average age of 57.1 ± 19.5 and 93 women (42.3%) with an average age of 57.1 ± 21.0. There were no significant differences in demographic characteristics between the groups. There was no significant difference in the dose or frequency of morphine administration between groups. There was no significant difference between the groups in pain scores and vital signs at different time points. Drug side effects, including delirium and gastrointestinal symptoms, did not differ significantly between the methadone and ketamine groups. Our clinical data support the hypothesis that ketamine is not inferior to methadone in patients with addiction. Future randomize clinical trials are needed to confirm these observations.